Introduction

43
Phosphoinositide-3-kinases (PI3Ks) are a family of lipid kinases that play a role 
55
In mammals, the PI3K family is formed by eight different catalytic PI3K (12,13). However, the exact mechanism by which this kinase is participating in 93 this process is still unknown.
94
In the epidermal squamous cell carcinoma (ESCC) cells A431, the 95 overexpression of PI3KC2β has been reported to enhance membrane ruffling, 96 migration speed of the cells, protection from anoikis and cell proliferation (14).
97
We decided to assess if some of these previously reported effects could be 98 consequence of a possible process of EMT induced in these cells after the 
152
Primary antibodies were detected using goat anti-rabbit IR680 (1/10'000, 
Proliferation assays
159
The EGFR kinase inhibitors, Gefitinib and Erlotinib, were purchased from with a microplate reader and normalized to the DMSO control. Dose-response 168 curves were carried out by using the medium described previously. Table 1 .
176
PCR reactions were performed in a ViiA7 cycler (Applied Biosciences) using cells/well in 100 µl of medium around the stoppers and left to attach for 24 h.
222
Next day, the stoppers were removed, and phase-contrast images were 223 acquired from each well every 2-4 h. The wound area was determined from 224 these images after delineating the edges digitally using Adobe Photoshop CS4 225 software.
227
Statistical analysis
228
Data is presented as average ± SD. All experiments were performed in triplicates.
229
Statistical analyses were conducted using GraphPad Prism 7 (GraphPad 230 Software). The statistical test used is indicated in the respective figure legend. P 231 < 0.05 was considered as statistically significant.
232
Crespo et al, initial manuscript.
233
Results
234
The overexpression of PI3KC2β changes the migration front of A431 1A). We then tested the effect of this overexpression in terms of cellular migration.
241
The PI3KC2β overexpressing cells presented increase in wound healing closure 242 speed compared to the parental cell line A431 (Fig 1B) . During these migration (Fig 1C) .
247
PI3KC2β overexpression increases EMT markers expression.
248
Following the primary observation, the levels of EMT markers in A431 and showed staining mainly at the plasma membrane, A431C2β cells, showed 262 staining at both the plasma membrane and in a cytoplasmic region close to the 263 nucleus ( Fig 3A) .
264
To better define the cytosolic sub compartment of the cell where E- with E-Cadherin was also performed revealed partial co-localization of these 276 proteins in the cytoplasm (Fig 4A) .
277
We performed here a dual-color immunofluorescence staining of EGFR 278 with E-cadherin (Fig 4B) . The overlap of the two signals in the cytoplasm showed to beta-Actin, since a strong increase of total-ERK was also found (Fig 5C) .
293
PI3KC2β has also been suggested to participate in chemo-resistance to 294 different drugs (6-8 (Fig 6A) . Furthermore, HT29C2β cells also showed 315 increased mRNA levels for SNAI1 (2.5 folds) (Fig 6B) . Finally, the comparison of 316 the morphology of the migration front between HT29 and HT29C2β cells showed 317 in HT29 an apparent tighter cell-to-cell contacts than in HT29C2β (Fig 6C) . 
EMT transcription factors (12).
340
In A431, the induction of EMT can be elicited by a chronic EGF treatment 341 that promotes the endocytosis of E-cadherin followed by the dissociation of the 342 E-cadherin/β-catenin complex and the subsequent trans-activation of the β-
343
catenin/lymphoid enhancer factor 1 (LEF-1) pathway (26,27). We are reporting
344
here that PI3KC2β overexpression is promoting a perinuclear localization of E-345 cadherin, β-catenin and EGFR instead of mainly at the plasma membrane (Fig   346   3A, 4A ). However, we were not able to determinate their specific cytoplasmic 347 localization as they do not co-localize with markers of Golgi apparatus or late 348 endosomes (Fig 3B-C) . Despite this, the proximity to late endosomes markers 349 suggest that these molecules could be localized in another type of endosomes.
350
A similar phenotype was observed in A431 after the treatment with 351 lysophosphatidic acid (LPA) (28). In this study E-cadherin and β-catenin were co- and being critical for cancer progression (28).
358
In our study, the dual-colour immunofluorescence staining of PI3KC2β
359
with E-Cadherin revealed a partial co-localization of these proteins in a similar 360 discrete perinuclear region (Fig 4A) . This supports the hypothesis that PI3KC2β
361
could be promoting the internalization of E-cadherin, β-catenin and EGFR.
362
PI3KC2β is one of the major producers of PI3P in endosomes (29). Moreover, an stabilization of cell-cell adhesion and probably leading to EMT (Fig 7) (28).
374
In addition to the observed effect in the cellular localization of EGFR, a 375 decrease in EGFR expression was also reported after PI3KC2β overexpression
376
( Fig 5B) . This observation is in agreement with previous studies showing that in ( Fig 5C) . This reduction was less remarkable when compared to β-Actin levels,
381
since a strong increase of total-ERK was also found (Fig 5C) , suggesting in 382 addition a possible compensatory mechanism.
383
Together with the decrease in EGFR expression, a reduced sensitivity to 384 the Erlotinib and Gefitinib was also observed (Fig 5D) . This is in agreement with 385 the transition to a mesenchymal-like phenotype that is known to decrease the 386 cellular dependence on EGFR signalling, as alternative growth pathways are 387 activated (31) (Fig 7) . This has been confirmed in different clinical trials where
388
NSCLC with high expression of E-cadherin showed a beneficial response to Additionally, PI3KC2β has also been suggested to participate in the 396 resistance to different chemotherapeutic compounds like tamoxifen, cisplatin,
397
Etoposide and Doxorubicin (18, 19, 35 
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Size bar = 50µm. Snail. This constitutes the transcriptional machinery that will lead to EMT. 
